Android app on Google Play

Ampio Pharma (AMPE) Founder, CEO Extend Lock-Up Agreements

July 3, 2012 7:13 AM EDT Send to a Friend
Get Alerts AMPE Hot Sheet
Trade AMPE Now!
Join SI Premium – FREE
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), reports that Dr. David Bar-Or, Ampio's Founder, Chief Scientific Officer and largest shareholder, and Michael Macaluso, Ampio's CEO, Chairman and Lead Investor, have extended their July 15th 2012 lock-up agreement until January of 2013. This extended lockup encompasses more than two-thirds of the company's shares owned by executives, management and directors.

You May Also Be Interested In

Related Categories

Insiders' Blog

Add Your Comment